Cordonnier et al. evaluated circulating exosomal-PD-L1 in melanoma patients by using an enzyme-linked immunosorbent assay, demonstrating a correlation with response to immunotherapy and clinical outcome (Cordonnier et al., 2020). The gene discussed is CD274; the disease is melanoma.